PEPFAR, UNAIDS to announce new plan for preventing MTCT of HIV

NewsGuard 100/100 Score
Jun 9 2011

At the U.N. High Level Meeting on AIDS, PEPFAR "will join with UNAIDS and other partners in releasing a new global action plan for the prevention of mother-to-child-transmission of HIV/AIDS. The U.S. will also place additional resources into helping move towards eliminating pediatric HIV," according to a State Department press release. "President Obama and Secretary Clinton remain unwavering in their longstanding commitment to fight global AIDS. During her trip to Africa later this week, Secretary Clinton will highlight the progress being made against HIV/AIDS," the release adds (6/7).

http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Child Health News | Women's Health News | Healthcare News

Tags: , , , , , , ,

Comments (0)

Suggested Reading

Global HIV epidemic cannot be ended without keeping former prisoners, other patients engaged in care
Breakthrough study offers hope for an effective HIV cure
New report on HIV drug resistance: Challenges and recommendations
U-M research offers a new path forward in the development of anti-HIV drugs
New drug candidates show promise to reverse HIV immune evasion
Study reveals increased risk of immune abnormalities in children of women with HIV
Common HIV drugs linked to reduced Alzheimer's disease risk
Research validates concurrent use of HIV medications and gender-affirming hormone therapy

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Unveiling the key role of RNA modification in HIV-1 survival and replication